MyAverix Finance
NS · Pharmaceuticals
Laurus Labs Ltd (LAURUSLABS)
Pharmaceuticals & Biotechnology
Laurus Labs Ltd (LAURUSLABS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $799.80B, P/E ratio is 107.98, net margin is 7.9%, dividend yield is 0.08%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LAURUSLABS
Laurus Labs Ltd (LAURUSLABS) — FAQ
What is Laurus Labs Ltd's market cap?
Laurus Labs Ltd (LAURUSLABS) has a reported market cap of $799.80B (data as of 2026-07-10).
What is LAURUSLABS's P/E ratio?
The price-to-earnings (P/E) ratio for Laurus Labs Ltd (LAURUSLABS) is 107.98 (data as of 2026-07-10).
Does Laurus Labs Ltd pay a dividend?
Laurus Labs Ltd (LAURUSLABS) shows a reported dividend yield of 0.08%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Laurus Labs Ltd in?
Laurus Labs Ltd (LAURUSLABS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is LAURUSLABS listed on?
LAURUSLABS is listed on NS.
What is Laurus Labs Ltd's net margin?
Laurus Labs Ltd (LAURUSLABS) reports a net margin of 7.9% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.